Detalles de la búsqueda
1.
Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
Cardiol Ther
; 8(1): 29-41, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30701401
2.
Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.
Cardiol Ther
; 8(1): 55-67, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30758783
3.
Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up.
Clin Res Cardiol
; 108(5): 520-538, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30298424
4.
A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease.
Clin Pharmacol Ther
; 104(2): 311-316, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29672821
5.
Low levels of apolipoprotein-CII in normotriglyceridemic patients with very premature coronary artery disease: Observations from the MISSION! Intervention study.
J Clin Lipidol
; 11(6): 1407-1414, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28882587
Resultados
1 -
5
de 5
1
Próxima >
>>